Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7254)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Nov 26, 2022 (publication date) through Sep 10, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Olagunju A, Yamani N, Kenny D, Mookadam M, Mookadam F, Unzek S. Potential for sodium-glucose cotransporter-2 inhibitors in the management of metabolic syndrome: A systematic review and meta-analysis. World J Cardiol 2022; 14(11): 599-616 [PMID: 36483765 DOI: 10.4330/wjc.v14.i11.599] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v14/i11/599.htm |
| Number | Citing Articles |
| 1 |
Benson M. Hamooya, Lukundo Siame, Lweendo Muchaili, Sepiso K. Masenga, Annet Kirabo. Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1661603
|
| 2 |
І. М. Кліщ. МЕТАБОЛІЧНИЙ СИНДРОМ: ПОГЛЯД НА ПРОБЛЕМУ. Здобутки клінічної і експериментальної медицини 2024; (1): 17 doi: 10.11603/1811-2471.2024.v.i1.14523
|
| 3 |
Milton Packer. The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction. JACC 2025; doi: 10.1016/j.jacc.2025.06.055
|
| 4 |
Maria Cristina Costa de Almeida, Marildes Luiza Castro, Larissa Espíndola, Luciana Nicolau Aranha, Thaís Salim, Gláucia Maria Moraes de Oliveira. One Size Does Not Fit All: The Need to Rethink the Metabolic Syndrome in Women. International Journal of Cardiovascular Sciences 2023; 36 doi: 10.36660/ijcs.20230101
|
| 5 |
Lance Sloan. SGLT2 inhibitors across the spectrum of chronic kidney disease: a narrative review. Postgraduate Medicine 2024; 136(8): 801 doi: 10.1080/00325481.2024.2418795
|
| 6 |
Lubna Islam, Dhanya Jose, Mohammed Alkhalifah, Dania Blaibel, Vishnu Chandrabalan, Joseph M Pappachan. Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience. World Journal of Diabetes 2024; 15(3): 463-474 doi: 10.4239/wjd.v15.i3.463
Abstract(600) |
Core Tip(647) |
Full Article(HTML)(2879)
|
Full Article with Cover (PDF)-1271K(206)
|
Full Article (Word)-381K(1)
|
Audio-1428K(10)
|
Peer-Review Report-175K(93)
|
Answering Reviewers-179K(93)
|
Full Article (PDF)-893K(262)
|
Full Article (XML)-122K(103)
|
Times Cited (5)
|
Total Visits (9088)
|
Open
|
| 7 |
Yang Xu, Zixu Zhao, Hui Xu, Chao Jiang, Xiao Wang, Zejun Yang, Wenyu Shao, Hang Guo, Liu He, Qi Guo, Caihua Sang, Deyong Long, Xin Du, Jianzeng Dong, Changsheng Ma. Impact of Sodium‐Glucose Cotransporter 2 Inhibitor on Recurrence After Catheter Ablation for Atrial Fibrillation in Patients With or Without Metabolic Syndrome. Journal of Cardiovascular Electrophysiology 2025; doi: 10.1111/jce.70073
|